I live in New Zealand, which has a centralised purchasing agency for pharmaceuticals (called Pharmac). The TPP doesn't require New Zealand to disband Pharmac. It can still negotiate reduced prices on behalf of the Kiwi public. The only change is that there is a more rigorous feedback and appeal process, which seems perfectly reasonable to me.